My “Runners” Strategy Explained (Part I): The Philosophy
We’re well-positioned in six open trades, including our latest one on Catalyst Pharma Inc., which is off to a strong start.
Read MoreArchive Category: Max Profit Alert Archive
Catalyst Pharma (CPRX) Trade Update: Earnings, High Stock Rating and Our Entry
Yesterday, we bought call options on Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX). In the trade alert, I described it as a “rare bird” in the biotech and pharmaceuticals space.
Read More322% on OZK, 213% on MRO, 121% on EXPD: A Terrific Start to the Month!
Last November was a “hold your breath” moment for financial markets, as everyone waited to learn the outcome of the U.S. presidential election. Once it was more or less resolved, we saw a new wave of sector-specific trends unleashed.
Read MoreEarnings Update: MMM & OZK… Plus, More About the VXX Reverse Split
First, if you’ve been with me since the “B.C.” days (that is, Before Coronavirus) … congratulations on the 60% profit you locked in on the “short volatility” trade we made on March 20, 2020.
Read MoreWeekly Update: Why “Going Up” Is Key to Our Strategy
First, congratulations on your 60%-plus profit on your SPDR Utilities Sector ETF (NYSE: XLU) play! I wrote two weeks ago about the potential for interest rates to turn lower and how that would put a tailwind behind the utilities sector.
Read MoreWatchlist
